$康方生物(09926)$ $Summit Therapeutics(SMMT)$ #创新药#1L EGFRwt sq非小在ELCC似乎要更新一些新的数据了?Title:Phase 2 Results of Ivonescimab a Novel PD-1/VEGF Bispecific in Combination with Chemotherapy for First Line Treatment of Patients with Advanced / Metastatic ...